Robeco Institutional Asset Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Robeco Institutional Asset Management's RPRX Position: Q3 2026 in Review
Robeco Institutional Asset Management increased its Royalty Pharma (RPRX) stake by 28% in Q3 2026, buying an estimated $15.2M and bringing the position to 1,168,427 shares worth $68.2M. The position accounts for 0.08% of the portfolio, ranked #234.
Robeco Institutional Asset Management first reported a position in RPRX in Q1 2021 and has held it in 23 quarters since. 705 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- Robeco Institutional Asset Management held 1,168,427 shares of Royalty Pharma worth $68.2M as of Q3 2026.
- Robeco Institutional Asset Management bought 256,841 Royalty Pharma shares in Q3 2026, an estimated $15.2M.
- Royalty Pharma made up 0.08% of Robeco Institutional Asset Management's portfolio in Q3 2026, its #234 holding.
- Robeco Institutional Asset Management first reported a position in Royalty Pharma in Q1 2021 and has held it in 23 quarters since.
- 705 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on Robeco Institutional Asset Management's 13F filing for Q3 2026, filed 20 Oct 2026.